View in EDS

Real-world use and outcomes of hyperthermic intra-peritoneal chemotherapy for stage III ovarian cancer.

Saved in:
Bibliographic Details
Title: Real-world use and outcomes of hyperthermic intra-peritoneal chemotherapy for stage III ovarian cancer.
Authors: Lot Aronson S; Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Department of Gynecological Oncology, Amsterdam, The Netherlands; Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Department of Medical Oncology, Amsterdam, The Netherlands., van Stein RM; Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Department of Gynecological Oncology, Amsterdam, The Netherlands., Algera MD; Scientific Bureau, Dutch Institute for Clinical Auditing (DICA), Leiden, The Netherlands; Maastricht University Medical Center, Department of Obstetrics and Gynecology, Maastricht, The Netherlands; GROW- School for Oncology and Reproduction, Maastricht, The Netherlands., Lopez-Yurda M; The Netherlands Cancer Institute, Department of Biometrics, Amsterdam, The Netherlands., van der Aa MA; Netherlands Comprehensive Cancer Organization (IKNL), Department of Research & Development, Utrecht, The Netherlands., Lok CAR; Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Department of Gynecological Oncology, Amsterdam, The Netherlands; Center for Gynecologic Oncology Amsterdam, Amsterdam, The Netherlands., de Hingh IHJT; Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands., Sonke GS; Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Department of Medical Oncology, Amsterdam, The Netherlands., van Driel WJ; Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Department of Gynecological Oncology, Amsterdam, The Netherlands; Center for Gynecologic Oncology Amsterdam, Amsterdam, The Netherlands. Electronic address: w.v.driel@nki.nl.
Corporate Authors: Dutch OVHIPEC study group
Source: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2026 Jul; Vol. 36 (7), pp. 104500. Date of Electronic Publication: 2026 Jan 21.
Publication Type: Journal Article
Journal Info: Publisher: BMJ Country of Publication: United States NLM ID: 9111626 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-1438 (Electronic) Linking ISSN: 1048891X NLM ISO Abbreviation: Int J Gynecol Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41723064
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Real-world use and outcomes of hyperthermic intra-peritoneal chemotherapy for stage III ovarian cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Lot+Aronson+S%22">Lot Aronson S</searchLink>; Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Department of Gynecological Oncology, Amsterdam, The Netherlands; Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Department of Medical Oncology, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Stein+RM%22">van Stein RM</searchLink>; Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Department of Gynecological Oncology, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Algera+MD%22">Algera MD</searchLink>; Scientific Bureau, Dutch Institute for Clinical Auditing (DICA), Leiden, The Netherlands; Maastricht University Medical Center, Department of Obstetrics and Gynecology, Maastricht, The Netherlands; GROW- School for Oncology and Reproduction, Maastricht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Lopez-Yurda+M%22">Lopez-Yurda M</searchLink>; The Netherlands Cancer Institute, Department of Biometrics, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+der+Aa+MA%22">van der Aa MA</searchLink>; Netherlands Comprehensive Cancer Organization (IKNL), Department of Research & Development, Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Lok+CAR%22">Lok CAR</searchLink>; Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Department of Gynecological Oncology, Amsterdam, The Netherlands; Center for Gynecologic Oncology Amsterdam, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22de+Hingh+IHJT%22">de Hingh IHJT</searchLink>; Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Sonke+GS%22">Sonke GS</searchLink>; Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Department of Medical Oncology, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Driel+WJ%22">van Driel WJ</searchLink>; Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Department of Gynecological Oncology, Amsterdam, The Netherlands; Center for Gynecologic Oncology Amsterdam, Amsterdam, The Netherlands. Electronic address: w.v.driel@nki.nl.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22Dutch+OVHIPEC+study+group%22">Dutch OVHIPEC study group</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229111626%22">International journal of gynecological cancer : official journal of the International Gynecological Cancer Society</searchLink> [Int J Gynecol Cancer] 2026 Jul; Vol. 36 (7), pp. 104500. <i>Date of Electronic Publication: </i>2026 Jan 21.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BMJ%22">BMJ </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9111626 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1525-1438 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%221048891X%22">1048891X </searchLink><i>NLM ISO Abbreviation: </i>Int J Gynecol Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41723064
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.ijgc.2026.104500
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 104500
    Titles:
      – TitleFull: Real-world use and outcomes of hyperthermic intra-peritoneal chemotherapy for stage III ovarian cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Lot Aronson S
      – PersonEntity:
          Name:
            NameFull: van Stein RM
      – PersonEntity:
          Name:
            NameFull: Algera MD
      – PersonEntity:
          Name:
            NameFull: Lopez-Yurda M
      – PersonEntity:
          Name:
            NameFull: van der Aa MA
      – PersonEntity:
          Name:
            NameFull: Lok CAR
      – PersonEntity:
          Name:
            NameFull: de Hingh IHJT
      – PersonEntity:
          Name:
            NameFull: Sonke GS
      – PersonEntity:
          Name:
            NameFull: van Driel WJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2026 Jul
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1525-1438
          Numbering:
            – Type: volume
              Value: 36
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
              Type: main
ResultId 1